A detailed history of Mackenzie Financial Corp transactions in Johnson & Johnson stock. As of the latest transaction made, Mackenzie Financial Corp holds 3,349,395 shares of JNJ stock, worth $487 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
3,349,395
Previous 3,441,335 2.67%
Holding current value
$487 Million
Previous $503 Million 7.92%
% of portfolio
0.81%
Previous 0.8%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$145.48 - $167.38 $13.4 Million - $15.4 Million
-91,940 Reduced 2.67%
3,349,395 $543 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $8.3 Million - $9.07 Million
57,511 Added 1.7%
3,441,335 $503 Million
Q1 2024

May 10, 2024

SELL
$155.22 - $162.74 $814,594 - $854,059
-5,248 Reduced 0.15%
3,383,824 $535 Million
Q4 2023

Jan 30, 2024

SELL
$145.6 - $158.88 $16.8 Million - $18.3 Million
-115,188 Reduced 3.29%
3,389,072 $531 Million
Q3 2023

Oct 25, 2023

SELL
$155.75 - $174.48 $27.8 Million - $31.1 Million
-178,201 Reduced 4.84%
3,504,260 $546 Million
Q2 2023

Aug 03, 2023

BUY
$154.35 - $166.11 $34.4 Million - $37 Million
223,044 Added 6.45%
3,682,461 $610 Million
Q1 2023

Apr 24, 2023

SELL
$151.05 - $180.26 $32.6 Million - $38.9 Million
-216,055 Reduced 5.88%
3,459,417 $536 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $17.8 Million - $19.9 Million
110,889 Added 3.11%
3,675,472 $649 Million
Q3 2022

Oct 07, 2022

SELL
$161.33 - $179.52 $14.2 Million - $15.8 Million
-88,056 Reduced 2.41%
3,564,583 $582 Million
Q2 2022

Aug 10, 2022

BUY
$168.19 - $186.01 $13.3 Million - $14.7 Million
78,805 Added 2.21%
3,652,639 $648 Million
Q1 2022

May 13, 2022

BUY
$158.14 - $179.59 $55.2 Million - $62.7 Million
348,880 Added 10.82%
3,573,834 $633 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $35 Million - $38.9 Million
-224,636 Reduced 6.51%
3,224,954 $552 Million
Q3 2021

Nov 08, 2021

SELL
$161.5 - $179.47 $26.2 Million - $29.1 Million
-162,400 Reduced 4.5%
3,449,590 $557 Million
Q2 2021

Aug 11, 2021

SELL
$159.48 - $171.07 $2.15 Million - $2.31 Million
-13,482 Reduced 0.37%
3,611,990 $595 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $36.5 Million - $40.7 Million
238,668 Added 7.05%
3,625,472 $596 Million
Q4 2020

Feb 10, 2021

SELL
$137.11 - $157.38 $54.4 Million - $62.5 Million
-397,085 Reduced 10.49%
3,386,804 $533 Million
Q3 2020

Nov 13, 2020

SELL
$140.38 - $153.83 $8.55 Million - $9.37 Million
-60,887 Reduced 1.58%
3,783,889 $563 Million
Q2 2020

Aug 13, 2020

BUY
$128.81 - $155.51 $60.1 Million - $72.6 Million
466,618 Added 13.81%
3,844,776 $541 Million
Q1 2020

May 14, 2020

SELL
$111.14 - $153.99 $47.3 Million - $65.5 Million
-425,565 Reduced 11.19%
3,378,158 $443 Million
Q4 2019

Feb 13, 2020

BUY
$127.5 - $146.44 $11.7 Million - $13.5 Million
91,882 Added 2.48%
3,803,723 $555 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $67.8 Million - $75.9 Million
534,129 Added 16.81%
3,711,841 $480 Million
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $79 Million - $86.9 Million
-602,241 Reduced 15.93%
3,177,712 $443 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $28.4 Million - $31.6 Million
-225,829 Reduced 5.64%
3,779,953 $528 Million
Q4 2018

Feb 06, 2019

SELL
$122.84 - $147.84 $14 Million - $16.9 Million
-114,137 Reduced 2.77%
4,005,782 $517 Million
Q3 2018

Nov 15, 2018

BUY
$121.58 - $142.88 $1.3 Million - $1.53 Million
10,675 Added 0.26%
4,119,919 $569 Million
Q2 2018

Aug 13, 2018

BUY
$119.4 - $131.76 $25.3 Million - $27.9 Million
211,479 Added 5.43%
4,109,244 $499 Million
Q1 2018

May 14, 2018

SELL
$125.1 - $148.14 $43.3 Million - $51.2 Million
-345,829 Reduced 8.15%
3,897,765 $499 Million
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $198 Million - $216 Million
1,507,278 Added 55.08%
4,243,594 $593 Million
Q3 2017

Nov 13, 2017

SELL
$129.47 - $135.38 $7.23 Million - $7.56 Million
-55,849 Reduced 2.0%
2,736,316 $356 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,792,165
2,792,165 $369 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $380B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.